{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:27:28Z","timestamp":1795037248880,"version":"4.10.2"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Fakult\u00e4t Mannheim der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>CT-guided adaptive radiotherapy (aRT) based on HyperSight<jats:sup>TM<\/jats:sup>-CBCT provides high-quality imaging, allowing quantitative radiomic feature analysis as a monitoring tool. This study comprehensively evaluates the stability of radiomic features, as potential imaging biomarkers, in pelvic structures of prostate cancer patients treated with adaptive stereotactic body radiation therapy (SBRT). Between December 2023 and July 2024, 32 patients with localized prostate cancer underwent adaptive SBRT at the Ethos<jats:sup>\u00ae<\/jats:sup> linear accelerator (Varian, Siemens Healthineers) with HyperSight-CBCT imaging. Longitudinal stability was assessed by intraclass correlation coefficient (ICC) over five fractions of aRT for target structures and non-hollow organs at risk. In pooled organs at risk, 93.0% of features showed very high stability (ICC\u2009&gt;\u20090.9) compared to 67.4% in pooled target structures, indicating significantly lower stability for target structures (<jats:italic>p<\/jats:italic>\u2009=\u20090.00009129). Second-order features demonstrated greater stability than conventional and shape-based features (<jats:italic>p<\/jats:italic>\u2009=\u20090.0433, <jats:italic>p<\/jats:italic>\u2009=\u20090.0252). Fraction number significantly affected longitudinal prostate feature variability (<jats:italic>p<\/jats:italic>\u2009=\u20090.0135). This study comprehensively analyzed HyperSight-CBCT imaging to evaluate longitudinal stability of radiomic features during adaptive SBRT for prostate cancer. The trends observed will provide a framework for future CT-guided aRT studies, facilitating quantitative imaging analysis of radiological biomarkers for clinical translation and improving personalized treatment.<\/jats:p>","DOI":"10.1038\/s41598-025-99920-x","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T03:19:06Z","timestamp":1746587946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Longitudinal stability of HyperSightTM-CBCT based radiomic features in patients with CT guided adaptive SBRT for prostate cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Paula","family":"Cvachovec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia S.","family":"Bicu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Siefert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Eckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Willam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias F.","family":"Froelich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan O.","family":"Schoenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Buergy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Fleckenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Boda-Heggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Dreher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"issue":"1","key":"99920_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1088\/0031-9155\/42\/1\/008","volume":"42","author":"D Yan","year":"1997","unstructured":"Yan, D. et al. Adaptive radiation therapy. Phys. Med. Biol. 42(1), 123\u2013132 (1997).","journal-title":"Phys. Med. Biol."},{"issue":"1","key":"99920_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.radonc.2016.08.019","volume":"121","author":"DS M\u00f8ller","year":"2016","unstructured":"M\u00f8ller, D. S. et al. Adaptive radiotherapy for advanced lung cancer ensures target coverage and decreases lung dose. Radiother. Oncol. 121(1), 32\u201338 (2016).","journal-title":"Radiother. Oncol."},{"issue":"7","key":"99920_CR3","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3390\/cancers13071533","volume":"13","author":"H Almansour","year":"2021","unstructured":"Almansour, H. et al. prospective image quality and lesion assessment in the setting of MR-guided radiation therapy of prostate cancer on an MR-Linac at 1.5 T: A comparison to a standard 3 T MRI. Cancers 13(7), 1533. https:\/\/doi.org\/10.3390\/cancers13071533 (2021).","journal-title":"Cancers"},{"key":"99920_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.radonc.2021.12.013","volume":"167","author":"RL Christiansen","year":"2022","unstructured":"Christiansen, R. L. et al. Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment. Radiother. Oncol. 167, 165\u2013171 (2022).","journal-title":"Radiother. Oncol."},{"issue":"1","key":"99920_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13014-023-02340-2","volume":"18","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. Review of cone beam computed tomography based online adaptive radiotherapy: Current trend and future direction. Radiat. Oncol. 18(1), 144 (2023).","journal-title":"Radiat. Oncol."},{"issue":"3","key":"99920_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.semradonc.2019.02.004","volume":"29","author":"OL Green","year":"2019","unstructured":"Green, O. L., Henke, L. E. & Hugo, G. D. Practical clinical workflows for online and offline adaptive radiation therapy. Semin. Radiat. Oncol. 29(3), 219\u2013227 (2019).","journal-title":"Semin. Radiat. Oncol."},{"issue":"3","key":"99920_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.4066","volume":"6","author":"M Guberina","year":"2023","unstructured":"Guberina, M. et al. Comparison of online-onboard adaptive intensity-modulated radiation therapy or volumetric-modulated arc radiotherapy with image-guided radiotherapy for patients with gynecologic tumors in dependence on fractionation and the planning target volume margin. JAMA Netw. Open 6(3), e234066 (2023).","journal-title":"JAMA Netw. Open"},{"key":"99920_CR8","unstructured":"Archambault, Y., et al. Making on-line adaptive radiotherapy possible using artificial intelligence and machine learning for efficient daily re-planning. Med. Phys. Int. J. 8(2) (2020)."},{"issue":"3","key":"99920_CR9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.zemedi.2022.11.004","volume":"34","author":"S Wegener","year":"2024","unstructured":"Wegener, S. et al. Prospective risk analysis of the online-adaptive artificial intelligence-driven workflow using the Ethos treatment system. Z. Med. Phys. 34(3), 384\u2013396 (2024).","journal-title":"Z. Med. Phys."},{"key":"99920_CR10","unstructured":"Varian, HyperSight: A revolution in resolution (HyperSight Brochure RAD11063A). Available from: https:\/\/varian.widen.net\/s\/sd5kdw7wxv\/hypersight_brochure_rad11063_oct2022., 2024. (2023)."},{"issue":"5","key":"99920_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.14337","volume":"25","author":"E Kim","year":"2024","unstructured":"Kim, E. et al. Image quality characterization of an ultra-high-speed kilovoltage cone-beam computed tomography imaging system on an O-ring linear accelerator. J. Appl. Clin. Med. Phys. 25(5), e14337 (2024).","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"99920_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110458","volume":"200","author":"B Kunnen","year":"2024","unstructured":"Kunnen, B. et al. The added value of a new high-performance ring-gantry CBCT imaging system for prostate cancer patients. Radiother. Oncol. 200, 110458 (2024).","journal-title":"Radiother. Oncol."},{"key":"99920_CR13","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.1002\/mp.17325","volume":"51","author":"C Wessels","year":"2024","unstructured":"Wessels, C. et al. Technical note: Phantom-based evaluation of CBCT dose calculation accuracy for use in adaptive radiotherapy. Med. Phys. 51, 7492 (2024).","journal-title":"Med. Phys."},{"issue":"10","key":"99920_CR14","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ad3cb0","volume":"69","author":"D Lustermans","year":"2024","unstructured":"Lustermans, D. et al. Image quality evaluation of a new high-performance ring-gantry cone-beam computed tomography imager. Phys. Med. Biol. 69(10), 105018 (2024).","journal-title":"Phys. Med. Biol."},{"issue":"9","key":"99920_CR15","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.mri.2012.06.010","volume":"30","author":"V Kumar","year":"2012","unstructured":"Kumar, V. et al. Radiomics: The process and the challenges. Magn. Reson. Imaging 30(9), 1234\u20131248 (2012).","journal-title":"Magn. Reson. Imaging"},{"issue":"12","key":"99920_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin, P. et al. Radiomics: The bridge between medical imaging and personalized medicine. Nat. Rev. Clin. Oncol. 14(12), 749\u2013762 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"99920_CR17","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ijrobp.2014.11.030","volume":"91","author":"A Cunliffe","year":"2015","unstructured":"Cunliffe, A. et al. Lung texture in serial thoracic computed tomography scans: Correlation of radiomics-based features with radiation therapy dose and radiation pneumonitis development. Int. J. Radiat. Oncol. Biol. Phys. 91(5), 1048\u20131056 (2015).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"99920_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.radonc.2019.01.004","volume":"135","author":"JC Peeken","year":"2019","unstructured":"Peeken, J. C. et al. CT-based radiomic features predict tumor grading and have prognostic value in patients with soft tissue sarcomas treated with neoadjuvant radiation therapy. Radiother. Oncol. 135, 187\u2013196 (2019).","journal-title":"Radiother. Oncol."},{"issue":"4","key":"99920_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin, P. et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur. J. Cancer 48(4), 441\u2013446 (2012).","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"99920_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11282-011-0071-z","volume":"27","author":"J Chindasombatjaroen","year":"2011","unstructured":"Chindasombatjaroen, J. et al. Quantitative analysis of metallic artifacts caused by dental metals: Comparison of cone-beam and multi-detector row CT scanners. Oral. Radiol. 27(2), 114\u2013120 (2011).","journal-title":"Oral. Radiol."},{"issue":"9","key":"99920_CR21","first-page":"e778","volume":"8","author":"L Lechuga","year":"2016","unstructured":"Lechuga, L. & Weidlich, G. A. Cone Beam CT vs. Fan Beam CT: A comparison of image quality and dose delivered between two differing CT imaging modalities. Cureus 8(9), e778 (2016).","journal-title":"Cureus"},{"issue":"6","key":"99920_CR22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.4103\/2231-0762.170523","volume":"5","author":"AK Nagarajappa","year":"2015","unstructured":"Nagarajappa, A. K., Dwivedi, N. & Tiwari, R. Artifacts: The downturn of CBCT image. J. Int. Soc. Prev. Commun. Dent. 5(6), 440\u2013445 (2015).","journal-title":"J. Int. Soc. Prev. Commun. Dent."},{"issue":"7","key":"99920_CR23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s11547-015-0496-2","volume":"120","author":"C Nardi","year":"2015","unstructured":"Nardi, C. et al. Metal and motion artifacts by cone beam computed tomography (CBCT) in dental and maxillofacial study. Radiol. Med. 120(7), 618\u2013626 (2015).","journal-title":"Radiol. Med."},{"key":"99920_CR24","first-page":"e0801","volume":"40","author":"M Balbi","year":"2024","unstructured":"Balbi, M. et al. Longitudinal changes of CT-radiomic and systemic inflammatory features predict survival in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors. J. Thorac. Imaging 40, e0801 (2024).","journal-title":"J. Thorac. Imaging"},{"issue":"1","key":"99920_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13014-022-02136-w","volume":"17","author":"NB Chen","year":"2022","unstructured":"Chen, N. B. et al. CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment. Radiat. Oncol. 17(1), 184 (2022).","journal-title":"Radiat. Oncol."},{"key":"99920_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.radonc.2019.03.032","volume":"136","author":"JE van Timmeren","year":"2019","unstructured":"van Timmeren, J. E. et al. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence. Radiother. Oncol. 136, 78\u201385 (2019).","journal-title":"Radiother. Oncol."},{"issue":"10","key":"99920_CR27","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00066-020-01677-x","volume":"196","author":"DG Bosetti","year":"2020","unstructured":"Bosetti, D. G. et al. Cone-beam computed tomography-based radiomics in prostate cancer: A mono-institutional study. Strahlenther Onkol. 196(10), 943\u2013951 (2020).","journal-title":"Strahlenther Onkol."},{"issue":"1","key":"99920_CR28","doi-asserted-by":"publisher","first-page":"20136","DOI":"10.1038\/s41598-022-24435-8","volume":"12","author":"R Delgadillo","year":"2022","unstructured":"Delgadillo, R. et al. Cone-beam CT delta-radiomics to predict genitourinary toxicities and international prostate symptom of prostate cancer patients: A pilot study. Sci. Rep. 12(1), 20136 (2022).","journal-title":"Sci. Rep."},{"issue":"11","key":"99920_CR29","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","volume":"20","author":"DH Brand","year":"2019","unstructured":"Brand, D. H. et al. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): Acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol. 20(11), 1531\u20131543 (2019).","journal-title":"Lancet Oncol."},{"issue":"16","key":"99920_CR30","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche, C. et al. LIFEx: A freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 78(16), 4786\u20134789 (2018).","journal-title":"Cancer Res."},{"issue":"2","key":"99920_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo, T. K. & Li, M. Y. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J. Chiropr. Med. 15(2), 155\u2013163 (2016).","journal-title":"J. Chiropr. Med."},{"issue":"3","key":"99920_CR32","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/jmri.26243","volume":"49","author":"T Chen","year":"2019","unstructured":"Chen, T. et al. Prostate cancer differentiation and aggressiveness: assessment with a radiomic-based model vs. PI-RADS v2. J. Magn. Reson. Imaging 49(3), 875\u2013884 (2019).","journal-title":"J. Magn. Reson. Imaging"},{"issue":"46","key":"99920_CR33","doi-asserted-by":"publisher","first-page":"E6265","DOI":"10.1073\/pnas.1505935112","volume":"112","author":"D Fehr","year":"2015","unstructured":"Fehr, D. et al. Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images. Proc. Natl. Acad. Sci. USA 112(46), E6265\u2013E6273 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"99920_CR34","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1007\/s00066-020-01679-9","volume":"196","author":"R Delgadillo","year":"2020","unstructured":"Delgadillo, R. et al. The role of radiomics in prostate cancer radiotherapy. Strahlenther Onkol. 196(10), 900\u2013912 (2020).","journal-title":"Strahlenther Onkol."},{"issue":"2","key":"99920_CR35","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ijrobp.2019.06.2504","volume":"105","author":"SOS Osman","year":"2019","unstructured":"Osman, S. O. S. et al. Computed tomography-based radiomics for risk stratification in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 105(2), 448\u2013456 (2019).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"99920_CR36","first-page":"685","volume":"38","author":"S Tanadini-Lang","year":"2018","unstructured":"Tanadini-Lang, S. et al. Exploratory radiomics in computed tomography perfusion of prostate cancer. Anticancer Res. 38(2), 685\u2013690 (2018).","journal-title":"Anticancer Res."},{"key":"99920_CR37","doi-asserted-by":"publisher","first-page":"1060687","DOI":"10.3389\/fonc.2023.1060687","volume":"13","author":"JCF Ching","year":"2023","unstructured":"Ching, J. C. F. et al. Integrating CT-based radiomic model with clinical features improves long-term prognostication in high-risk prostate cancer. Front. Oncol. 13, 1060687 (2023).","journal-title":"Front. Oncol."},{"issue":"3","key":"99920_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.radonc.2017.04.016","volume":"123","author":"JE van Timmeren","year":"2017","unstructured":"van Timmeren, J. E. et al. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images. Radiother. Oncol. 123(3), 363\u2013369 (2017).","journal-title":"Radiother. Oncol."},{"issue":"5","key":"99920_CR39","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mp.14787","volume":"48","author":"R Delgadillo","year":"2021","unstructured":"Delgadillo, R. et al. Repeatability of CBCT radiomic features and their correlation with CT radiomic features for prostate cancer. Med. Phys. 48(5), 2386\u20132399 (2021).","journal-title":"Med. Phys."},{"issue":"2","key":"99920_CR40","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijrobp.2021.10.137","volume":"113","author":"R Hannan","year":"2022","unstructured":"Hannan, R. et al. SABR for high-risk prostate cancer: A prospective multilevel mri-based dose escalation trial. Int. J. Radiat. Oncol. Biol. Phys. 113(2), 290\u2013301 (2022).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"99920_CR41","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1200\/JCO.20.02873","volume":"39","author":"LGW Kerkmeijer","year":"2021","unstructured":"Kerkmeijer, L. G. W. et al. Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: Results from the FLAME randomized phase III trial. J. Clin. Oncol. 39(7), 787\u2013796 (2021).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"99920_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.radonc.2014.07.016","volume":"113","author":"G Decker","year":"2014","unstructured":"Decker, G. et al. Intensity-modulated radiotherapy of the prostate: dynamic ADC monitoring by DWI at 3.0 T. Radiother. Oncol. 113(1), 115\u2013120 (2014).","journal-title":"Radiother. Oncol."},{"issue":"4","key":"99920_CR43","doi-asserted-by":"publisher","first-page":"e607","DOI":"10.1016\/j.crad.2023.12.022","volume":"79","author":"FB Franco","year":"2024","unstructured":"Franco, F. B. et al. Early change in apparent diffusion coefficient as a predictor of response to neoadjuvant androgen deprivation and external beam radiation therapy for intermediate- to high-risk prostate cancer. Clin. Radiol. 79(4), e607\u2013e615 (2024).","journal-title":"Clin. Radiol."},{"issue":"3","key":"99920_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.radonc.2011.08.012","volume":"100","author":"A Bertelsen","year":"2011","unstructured":"Bertelsen, A. et al. Radiation dose response of normal lung assessed by Cone Beam CT \u2013 A potential tool for biologically adaptive radiation therapy. Radiother. Oncol. 100(3), 351\u2013355 (2011).","journal-title":"Radiother. Oncol."},{"issue":"1","key":"99920_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.radonc.2015.07.021","volume":"117","author":"U Bernchou","year":"2015","unstructured":"Bernchou, U. et al. Prediction of lung density changes after radiotherapy by cone beam computed tomography response markers and pre-treatment factors for non-small cell lung cancer patients. Radiother. Oncol. 117(1), 17\u201322 (2015).","journal-title":"Radiother. Oncol."},{"issue":"4","key":"99920_CR46","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/1759-7714.13349","volume":"11","author":"Q Qin","year":"2020","unstructured":"Qin, Q. et al. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients. Thorac. Cancer 11(4), 964\u2013972 (2020).","journal-title":"Thorac. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99920-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99920-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99920-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T04:03:33Z","timestamp":1746590613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99920-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99920"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99920-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"29 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DB reports NB Capital ApS (Consultation, personal fees), PharmaMar GmbH (speaker), AstraZeneca GmbH (speaker). FG reports travel expenses, stocks and honoraria from TME Pharma AG related to this work; research grants and travel expenses from ELEKTA AB; grants, research grants, travel expenses and honoraria from Carl Zeiss Meditec AG; grants, research grants, travel expenses and honoraria from OncoMANGETx, Inc.; travel expenses and research grants from Varian Medical Systems, Inc.; travel expenses and\/or honoraria from Bristol- Myers Squibb, Cureteq AG, Roche Pharma AG, MSD Sharp and Dohme GmbH, Siemens Healthineers AG, Varian Medical Systems, and AstraZeneca GmbH; non-financial support from Oncare GmbH and Opasca GmbH and patent US10857388B2 together with Carl Zeiss Meditec AG and patent EP4119191A1.  JBH reports AstraZeneca speaker fees and consulting honoraria EbaMed SA. CD reports Varian research grant and travel expenses, AstraZeneca speaker fees and travel expenses, and DGVS speaker fees and travel expenses. All other authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15863"}}